Peptide stacks · Sexual health and tanning
PT-141 and Melanotan II stack: what’s in it and the evidence
Checked against our library and study pagesPublished by PepVault
The PT-141 and Melanotan II stack is two compounds run side by side, each from its own vial or form: PT-141 and Melanotan II. The library records PT-141 at 0.5–2 mg and Melanotan II at 250–500 mcg per dose as reference ranges.
This page describes what the crowd runs and what a vial holds. It recommends no stack and names no seller.
What’s in the PT-141 and Melanotan II stack
| Part | Reference range | Filed under | Evidence (library) |
|---|---|---|---|
| PT-141 | 0.5–2 mg | Sexual desire, CNS-based arousal, FDA-approved | Established |
| Melanotan II | 250–500 mcg | Tanning, Libido boost, Appetite suppression | Emerging |
The library’s reference range per dose, part by part
PT-141
PT-141 is one of the two parts of the PT-141 and Melanotan II stack. An FDA-approved, as-needed treatment for low sexual desire in premenopausal women that acts through brain melanocortin receptors rather than blood flow (flibanserin/Addyi is the other, daily option).
Melanotan II
Melanotan II is one of the two parts of the PT-141 and Melanotan II stack. A broad-spectrum melanocortin agonist originally developed for sunless tanning.

Has the PT-141 and Melanotan II stack been studied as a combination?
None of our 436 study pages tested PT-141 and Melanotan II together, so the PT-141 and Melanotan II stack rests on studies of its parts and on community reports.
The studies of the parts, one by one: 6 study pages on PT-141 (6 in people) and 5 study pages on Melanotan II (5 in people).
| Part | Study pages | In people | Strongest study page |
|---|---|---|---|
| PT-141 | 6 | 6 | PT-141: side-effect dropouts far higher than placebo in re-analysis (meta-analysis, 2021) |
| Melanotan II | 5 | 5 | Melanotan II: erections in 17 of 20 men with erectile dysfunction (clinical trial, 2000) |
What people commonly report on the PT-141 and Melanotan II stack
The library holds no report of what people notice on the PT-141 and Melanotan II stack as a pair. What it records for each part on its own:
- PT-141: a noticeable rise in desire and arousal an hour or so after dosing (men often describe firmer or spontaneous erections), nausea that is often worst with the first dose, facial flushing, and headache on dosing days.
- Melanotan II: nausea and facial flushing after the first doses, easing with continued use; a fast, deep tan with freckles and moles visibly darkening; and spontaneous erections, frequent yawning and reduced appetite.
These are reports from people who run it, collected in the library, not results from a trial and not a promise of what any one person will notice.
Why these are combined
“PT-141 + MT-2: targeted vs broad”, the PT-141 entry’s note (community report)
PT-141 is a close analog of Melanotan II (it differs only at the tail end of the molecule), developed for sexual function after MT-II caused erections; it didn't drop the tanning receptor. Some use MT-2 for tanning and PT-141 for targeted as-needed arousal. Both activate MC4R (libido) and MC1R (tanning).
“MT-2 is PT-141's parent compound”, the Melanotan II entry’s note (community report)
PT-141 is a close analog of MT-2 that was developed specifically for sexual function. MT-2 is the broader tool; PT-141 is the as-needed one. MT-2 activates MC1R/MC3R/MC4R broadly. PT-141 (bremelanotide) is MT-2's C-terminal acid analog (same ring structure); it is still a nonselective melanocortin agonist and still causes skin darkening with frequent use. Using both hits the same receptor population.
How the parts of the PT-141 and Melanotan II stack are mixed and taken
The PT-141 and Melanotan II stack isn’t one pre-mixed vial in the library: each part has its own route and schedule, as its entry records them.
| Part | Route | How often | Our vial pages |
|---|---|---|---|
| PT-141 | SubQ injection | As needed, 1–2 hours before | 10 mg vial |
| Melanotan II | SubQ injection | Loading: 250mcg daily for 1-2 weeks. Maintenance: 250-500mcg 2-3x/week or as needed. | 5 mg vial |
Our vial pages work out the mix for each part’s own vial, size by size:
Compared with running the parts apart
What the library says about the PT-141 and Melanotan II stack against its parts on their own:
- Stacking both is redundant for libido — they hit the same receptors.
Safety notes
From the library’s notes on the combination
Combining them raises hyperpigmentation risk without additive sexual arousal benefit.
These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.
Questions people ask
What is in the PT-141 and Melanotan II stack?
The PT-141 and Melanotan II stack is two compounds run side by side, each from its own vial or form: PT-141 and Melanotan II. The library records PT-141 at 0.5–2 mg and Melanotan II at 250–500 mcg per dose as reference ranges.
Has the PT-141 and Melanotan II stack been studied together?
Not as a combination in any of our study pages: the PT-141 and Melanotan II stack rests on studies of its parts and on community reports.
Do the parts of the PT-141 and Melanotan II stack come in one vial?
No: in the library each part of the PT-141 and Melanotan II stack is its own compound with its own route and schedule (PT-141 by SubQ injection and Melanotan II by SubQ injection).
What does each part of the PT-141 and Melanotan II stack do?
PT-141: An FDA-approved, as-needed treatment for low sexual desire in premenopausal women that acts through brain melanocortin receptors rather than blood flow (flibanserin/Addyi is the other, daily option). Melanotan II: A broad-spectrum melanocortin agonist originally developed for sunless tanning.
How does the PT-141 and Melanotan II stack compare with taking the parts separately?
From the library: Stacking both is redundant for libido — they hit the same receptors.